Sequence information
Variant position: 203 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1023 The length of the canonical sequence.
Location on the sequence:
GLRSKSQRPCVKADSTQDKK
A PMMQSQSRSCTELHKHLTSA
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human GLRSKSQRPCVKADSTQDKKA PMMQSQSRSCTELHKHLTSA
Mouse SLSSRSQRPCVKVDGTQDKKT PTLRAQSRPCTELHKHLTSV
Rat SLSSRSQRPCVKVDGTQDKKT PMLRSQSRPCTELHKHLTSV
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 1023
Peroxisome proliferator-activated receptor gamma coactivator 1-beta
Region
165 – 210
Disordered
Literature citations
Evidence of an association between genetic variation of the coactivator PGC-1beta and obesity.
Andersen G.; Wegner L.; Yanagisawa K.; Rose C.S.; Lin J.; Gluemer C.; Drivsholm T.; Borch-Johnsen K.; Jorgensen T.; Hansen T.; Spiegelman B.M.; Pedersen O.;
J. Med. Genet. 42:402-407(2005)
Cited for: POLYMORPHISM; VARIANTS PRO-203; ILE-279 AND SER-292;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.